Mirae Asset Global Investments Co., Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,652 shares of RARE stock, worth $124,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,652
Previous 3,095
18.0%
Holding current value
$124,058
Previous $112,000
17.86%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding RARE
# of Institutions
361Shares Held
88.3MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$347 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$190 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$134 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$98 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$94.2 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.38B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...